Skip to main content

Specialty Pharmacy

  • ViroPharma launches hereditary angioedema campaign

    EXTON, Pa. — Drug maker ViroPharma has launched an education campaign focused on a rare, debilitating and life-threatening genetic disorder.

    The company announced Wednesday the launch of the unbranded campaign focused on hereditary angioedema, particularly the emotional and psychological burden faced by patients with the disease, which results from deficiency of the human plasma protein C1 inhibitor and causes attacks of swelling and pain.

  • Aetna, Cardinal Health Specialty Solutions partner on evidence-based cancer care program in Michigan

    HARTFORD, Conn. — Aetna and Cardinal Health Specialty Solutions on Tuesday announced an evidence-based program designed to improve cancer care in Michigan. This pathways initiative identifies clinical practices that improve cancer treatment and make it more affordable.

  • FDA approves new indication for J&J prostate cancer drug

    SILVER SPRING, Md. — The Food and Drug Administration has approved a new use for a cancer drug made by Johnson & Johnson, the agency said Monday.

    The FDA announced the approval of Zytiga (abiraterone acetate), made by J&J subsidiary Janssen Biotech, for men with castration-resistant prostate cancer that has spread to other parts of the body, for use prior to receiving chemotherapy. The drug was already approved for castration-resistant prostate cancer in men who had already undergone chemotherapy treatment.

  • Amgen buys DeCode Genetics for $415 million

    THOUSAND OAKS, Calif. — Amgen is buying an Iceland-based biotech company for $415 million, the two said Monday.

    Amgen announced it would acquire DeCode Genetics, based in Reykjavik, Iceland, in a deal that Amgen's board of directors unanimously approved. Founded in 1996, DeCode focuses its business on finding links between the human genome and disease susceptibility. The acquisition is expected to close before the end of 2012 and does not require regulatory approval.

  • Reports: Congressional committee looking into compounding industry group's practices

    NEW YORK — A Congressional committee is looking into allegations that a compounding pharmacy industry association may have taught pharmacists how to sidestep requests for samples from the Food and Drug Administration, according to published reports.

    Reuters reported that the House Energy and Commerce Committee had requested internal documents from the International Academy of Compounding Pharmacists, citing a news report about the organization.

  • Diplomat Specialty Pharmacy named one of nation's top job creators

    FLINT, Mich. — Inc. magazine has named Diplomat Specialty Pharmacy as one of the country's top 100 job creators, the privately owned company said.

  • Mass. health department reorganizes pharmacy board, sanctions three compounding pharmacies amid meningitis outbreak

    BOSTON — The state health department in Massachusetts has made changes to the state's pharmacy board and leveled sanctions against three pharmacies in the wake of a nationwide meningitis outbreak traced to a compounding pharmacy in the state, the department said.

  • Walgreens and Cystic Fibrosis Foundation share joint ownership of specialty pharmacy

    DEERFIELD, Ill. — Walgreens and the Cystic Fibrosis Foundation on Friday announced they have completed a transaction giving Walgreens a significant ownership stake in Cystic Fibrosis Foundation Pharmacy, the parent company of Cystic Fibrosis Services.

    Terms of the agreement were not disclosed.

X
This ad will auto-close in 10 seconds